[1] MATHERS CD, LONCAR D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
[2] ZHANG P, LU J, JING Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106-116.
[3] IBRAHIM A. IDF Clinical Practice recommendation on the diabetic foot: a guide for healthcare professionals. Diabetes Res Clin Pract. 2017;127:285-287.
[4] APELQVIST J. Diagnostics and treatment of the diabetic foot. Endocrine. 2012;41(3): 384-397.
[5] SUN Y, GAO Y, CHEN J, et al. Evidence mapping of recommendations on diagnosis and therapeutic strategies for diabetes foot: an international review of 22 guidelines. Metabolism. 2019;100:153956.
[6] HINCHLIFFE RJ, BROWNRIGG JR, ANDROS G, et al. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2016;32 Suppl 1:136-144.
[7] CHEN Y, KUANG X, ZHOU J, et al. Proximal tibial cortex transverse distraction facilitating healing and limb salvage in severe and recalcitrant diabetic foot ulcers. Clin Orthop Relat Res. 2020;478(4):836-851.
[8] GUBIN AV, BORZUNOV DY, MARCHENKOVA LO, et al. Ilizarov to bone reconstruction: historical achievements and state of the art. Strategies Trauma Limb Reconstr. 2016; 11(3):145-152.
[9] ARONSON J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop Relat Res. 1994; (301):124-131.
[10] BEGUN A, MORBACH S, RUMENAPF G, et al. Study of disease progression and relevant risk factors in diabetic foot patients using a multistate continuous-time markov chain model. PLoS One. 2016;11(1):e147533.
[11] JADAD AR, MOORE RA, CARROLL D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
[12] STANG A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9): 603-605.
[13] 韦积华,唐乾利,罗群强,等.Ilizarov微循环重建技术对糖尿病足溃疡的临床疗效观察[J]. 右江民族医学院学报,2019, 41(3):239-245.
[14] 赵晓明,刘亮,贾中伟,等.胫骨横向搬移技术治疗糖尿病足的临床疗效[J].西安交通大学学报(医学版),2020,41(2):244-250.
[15] 徐军.胫骨横向骨搬移技术在糖尿病足治疗中的临床应用效果探讨[J].糖尿病新世界,2019,22(19):176-177.
[16] 邬予俭,何贵,林宝举,等.胫骨横向骨搬移技术治疗糖尿病足的疗效观察及研究[J].双足与保健,2018,27(13):79-80.
[17] 马敬伟,赵琳琳,马德春.胫骨横向骨搬移微循环再生技术治疗糖尿病足的临床疗效分析[J]. 黑龙江科学,2018,9(9):6-7.
[18] 西立峰.胫骨横向骨搬运技术治疗糖尿病足及下肢血管闭塞症的临床效果[J].中国实用医药,2019,14(15):63-64.
[19] 岑忠喜,曾高峰,何基琛,等.改良骨搬移治疗糖尿病足[J].中国组织工程研究, 2018,22(36):5766-5771.
[20] ZHIVOV A, PESCHEL S, SCHOBER HC, et al. Diabetic foot syndrome and corneal subbasal nerve plexus changes in congolese patients with type 2 diabetes. PLoS One. 2015;10(3):e119842.
[21] POP-BUSUI R, BOULTON AJ, FELDMAN EL, et al. Diabetic neuropathy: a position statement by the american diabetes association. Diabetes Care. 2017;40(1):136-154.
[22] LAVERY LA, PETERS EJ, WILLIAMS JR, et al. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2008;31(1):154-156.
[23] DAVIS FM, KIMBALL A, BONIAKOWSKI A, et al. Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep. 2018;18(1):2.
[24] HINCHLIFFE RJ, BROWNRIGG JR, ANDROS G, et al. Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2016;32 Suppl 1:136-144.
[25] BUS SA, ARMSTRONG DG, VAN DEURSEN RW, et al. IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1: 25-36.
[26] MUELLER MJ, SINACORE DR, HASTINGS MK, et al. Effect of achilles tendon lengthening on neuropathic plantar ulcers. a randomized clinical trial. J Bone Joint Surg Am. 2003; 85(8):1436-1445.
[27] ARMSTRONG DG, BOULTON A, BUS SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375.
[28] BUS SA. Priorities in offloading the diabetic foot. Diabetes Metab Res Rev. 2012;28 Suppl 1:54-59.
[29] 赵晓明,刘亮,袁启令,等.胫骨横向搬移技术治疗糖尿病足的研究进展[J/OL].中国修复重建外科杂志:1-5[2020-10-26].http://kns.cnki.net/kcms/detail/51.1372.R.20200416.1346.016.html.
[30] BARKER KL, LAMB SE, SIMPSON AH. Functional recovery in patients with nonunion treated with the Ilizarov technique. J Bone Joint Surg Br. 2004;86(1): 81-85.
[31] GREENMAN RL, PANASYUK S, WANG X, et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet. 2005;366(9498):1711-1717.
[32] ARORA S, POMPOSELLI F, LOGERFO FW, et al. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg. 2002;35(3):501-505.
[33] UCCIOLI L, GANDINI R, GIURATO L, et al. Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic. Diabetes Care. 2010;33(5):977-982.
[34] 镇普祥.横向骨搬移治疗重度糖尿病足疗效与血管再生现象研究[D].桂林:广西医科大学,2019.
[35] PATWA JJ, KRISHNAN A. Buerger’s disease (thromboangiitis obliterans)- management by ilizarov’s technique of horizontal distraction. a retrospective study of 60 cases. Indian J Surg. 2011;73(1):40-47.
[36] MARWAH V. Management of thromboangiitis obliterans using distraction osteogenesis: a retrospective study. Indian J Orthop. 2012;46(4):490.
[37] MARIE PJ, MIRAOUI H, SEVERE N. FGF/FGFR signaling in bone formation: progress and perspectives. Growth Factors. 2012;30(2): 117-123.
[38] 任国强,李炳辉,李恭驰,等.糖尿病创面基质金属蛋白酶9对血管内皮生长因子表达的影响[J].中华损伤与修复杂志(电子版),2017,12(2):123-127.
[39] 欧栓机,许长鹏,李贵涛,等.胫骨横向骨搬移对血清血管生成相关因子表达的影响[J]. 中国修复重建外科杂志, 2020,34(1):98-101.
[40] Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature. 2008; 453(7193):314-321.
[41] 高伟,林震迅,镇普祥,等.胫骨横向骨搬移后巨噬细胞促进重度糖尿病足创面的愈合[J]. 中国组织工程研究,2018,22(36):5811-5815.
|